BICO has acquired all outstanding shares in Advanced BioMatrix, an American company focusing on 3D research applications.
The Advanced BioMatrix portfolio includes collagen bioinks, high purity extracellular matrix proteins, chemically modified proteins and polysaccharides, and other reagents and